Suggested Searches

photo of Amy M Schell
859-276-0414

Amy M Schell, MD

Hematology Oncology
Gender: Female
4.9 of 5 (206 Ratings)
Accepting New Patients
Virtual Visits

Clinical Focus

Breast Cancer, Cancerous tumors, General oncology hematology

Practice Locations

A:
Baptist Health Medical Group Hematology & Oncology
1700 Nicholasville Road, Suite 1100
Lexington, KY 40503
859-276-0414 859-276-3765
B:
Baptist Health Medical Group Hematology & Oncology
793 Eastern Bypass, Building 3
Richmond, KY 40475
859-276-0414 859-276-3765

Education

Fellowship

Dartmouth-Hitchcock Medical Center

Residency

Dartmouth-Hitchcock Medical Center

Medical School

University of Kentucky College of Medicine

Fellowship

Washington University in St. Louis

Board Certifications

Hematology

American Board of Internal Medicine

Medical Oncology

American Board of Internal Medicine

Internal Medicine

American Board of Internal Medicine

Hospital Affiliations

  • Baptist Health Medical Group
  • Baptist Health Lexington
  • Baptist Health Richmond

Philosophy of Care

Baptist Health Medical Group is a comprehensive, multispecialty network of physicians and advanced practice clinicians. Our providers are committed to providing compassionate, patient-centered care and strive to treat our patients the way we would want to be treated, every time, at every Baptist Health location.

Research

  • Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anat

    A011801: The COMPASSHER2 Trials (Comprehensive Use Of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T=

    Trial Details
  • Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anat

    A011801: The COMPASSHER2 Trials (Comprehensive Use Of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T=

    Trial Details
  • Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anat

    A011801: The COMPASSHER2 Trials (Comprehensive Use Of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T=

    Trial Details
  • Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anat

    A011801: The COMPASSHER2 Trials (Comprehensive Use Of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T=

    Trial Details
  • A012103

    Trial Details
  • BR009

    Learn more.

    Trial Details
  • BR009

    Learn more.

    Trial Details
  • BR009

    Learn more.

    Trial Details
  • BR009

    Learn more.

    Trial Details
  • Breast Cancer (WIRB-22-0127)

    TOL2506A-EXT: Open-label, Safety Extension Study for Subjects with Hormone-Receptor Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Who Have Completed the OVarian Suppression Evaluating Subcutaneous LeuprolIde Acetate in Breast Cancer (OVELIA) Study.

    Trial Details
  • Tropion 05

    Learn more.

    Trial Details

About Amy M Schell

Reviews

Patient Experience Ratings

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Overall Rating
4.9 out of 5 (206 Ratings)
Review Categories
Patient Comments

Featured HealthTalks